logo

For the Inventor, By the Inventor

Boulder, CO, United States of America

James D Thompson

This inventor holds 19 USPTO granted patents and 6 EPO patents. Top assignees: Ribozyme Pharmaceuticals, Incorporated, Sirna Therapeutics, Inc.. Active years: 1997-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James D Thompson. Retrieved from https://idiyas.com/inventor/james-d-thompson-javed88f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.7

ph-index = 11

Forward Citations = 680(Granted Patents)


Location History:

  • Solon, OH (US) (1999)
  • Boulder, CO (US) (1997 - 2005)
  • Lafayette, CO (US) (2004 - 2014)

Company Filing History:

goldMedal16 out of 110 
 
Ribozyme Pharmaceuticals, Incorporated
 patents
silverMedal3 out of 140 
 
Sirna Therapeutics, Inc.
 patents

Years Active: 1997-2014

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 8846894 - RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) (2014-09-30),
2. 6852535 - Polymerase III-based expression of therapeutic RNAS (2005-02-08),
3. 6673611 - Nucleic acid molecules with novel chemical compositions capable of modulating gene expression (2004-01-06),
4. 6544755 - Method and reagent for treatment of diseases by expression of the c-Myc gene (2003-04-08),
5. 6492512 - Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression (2002-12-10),
6. 6448009 - Method for target site selection and discovery (2002-09-10),
7. 6183959 - Method for target site selection and discovery (2001-02-06),
8. 6159692 - Method and reagent for inhibiting human immunodeficiency virus (2000-12-12),
9. 6146886 - RNA polymerase III-based expression of therapeutic RNAs (2000-11-14),
10. 5989906 - Method and reagent for inhibiting P-glycoprotein (mdr-1-gene) (1999-11-23),
11. 5972704 - HIV nef targeted ribozymes (1999-10-26),
12. 5902880 - RNA polymerase III-based expression of therapeutic RNAs (1999-05-11),
13. 5801158 - Enzymatic RNA with activity to RAS (1998-09-01),
14. 5750390 - Method and reagent for treatment of diseases caused by expression of the (1998-05-12),
15. 5714383 - Method and reagent for treating chronic myelogenous leukemia (1998-02-03),

Title: The Inventor James D Thompson: Pioneering Innovations in Boulder

Introduction: James D Thompson is a renowned inventor based in Boulder, CO, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: James D Thompson holds several patents in the fields of renewable energy, sustainable technologies, and advanced materials, showcasing his commitment to developing solutions for a more sustainable future.

Career Highlights: With a career spanning over two decades, James D Thompson has worked with leading research institutions and companies to bring his inventions to life. His dedication to pushing the boundaries of technology has earned him recognition as a visionary in the field of innovation.

Collaborations: Throughout his career, James D Thompson has collaborated with top engineers, scientists, and designers to transform his ideas into tangible products that have made a significant impact on the market. His ability to work effectively in multidisciplinary teams has been key to his success.

Conclusion: James D Thompson's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to think boldly and create solutions that shape the world we live in.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…